[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Search published articles ::
Showing 8 results for Treatment

S.mohammandian (m.d), Hr.bazrafshan (m.d), A.sadeghi-Nejad (m.d),
Volume 5, Issue 2 (9-2003)
Abstract

Biosynthetic growth hormone is now available in virtually unlimited quantities. As a result because of its growth promoting and anabolic effects, it is widely used in various disorders in both children and adults. Growth hormone has been proven to be beneficial in a small number of diseases causing short stature in children, and in adults with severe growth hormone deficiency or acquired immunodeficiency syndrome (AIDS). The hormone is also used on an investigational basis in a variety of disorders causing short stature, as well as in the aged and in several catabolic conditions. It is likely that with time the indications for treatment with this hormone will be increased.
A.abassi (m.d), M.aarabi (m.d),
Volume 6, Issue 1 (3-2004)
Abstract

Background & Objective: About 1.3 billions people are infected with Tuberculosis (TB) all over the world. There is a close relationship between the quality of TB treatment and the rate of drug resistance. The recurrence epidemy of TB and increased resistance to some drugs was the basis for the WHO to suggest the directly observed short course treatment strategy or (DOTS) strategy, for the TB patients. Materials & Methods: This research was a cohort study and aimed to evaluate the epidemiological finding, the clinical basis and strategy of DOTS on improving, and prevention from failure of treatment and was compared with non-DOTS procedure. Sample population were total of 260 smear positive patients that had been under study for a period of 2 years (1999-2000). All of the patients were new cases. SPSS software and Fisher exact test was used to analyzed the data. Results: The rate of treatment failure in DOTS strategy in the beginning of 5th month was 1.7%, but in the control group the failure in the same period was 7.3% (P<0.05). Conclusion: This study indicated that the DOTS strategy is substantially increasing the success rate of TB treatment.
Mohammad Hadi Mehdinejad (msc), Bijan Bina(phd), Mahnaz Nikaeen(phd), Hossein Movahedian Attar(phd),
Volume 11, Issue 3 (10-2009)
Abstract

Background and Objective: In recent years, chitosan and Moringa oleifera Coagulant Protein a natural coagulant were used in order to reduce the problems occure from chemical coagulants. This investigation was done to determine effectiveness of Moringa Oleifera Coagulant Protein and Chitosan as natural coagulant aids in removal of colloidal particles and bacteria from turbid waters. Materials and Methods: In this interventional- quasi experimental study, the experiments were run by using synthetic water having low(10-20NTU), medium(100-120NTU) and high (200-220NTU) initial turbidities. In order to determine optimum pH and dosage of coagulant and coagulant aids, a conventional jar test apparatus was employed. Turbidity reading were carried out using a Hach model 2100P Turbidimeter. The samples were taken from the top four inch of the suspension for turbidity and bacteria removal measurement. Results: Optimum dose of alum for waters with three different initial turbidities were 20, 40, and 20 mg/l, respectively. Optimum pH was between 7-7.5. Moringa oleifera Coagulant Protein and chitosan were reduced the required dosage of alum from 12.5% to 62.5% and from 50% to 87.5%, respectively, in different turbidities and residual aluminum was reduced to standard limit (0.2mg/l). The bacteria removal efficiency were from 90% to 99.9999%. It was found when samples were stored during 24 hours regrowth of E.coli was not observed. Conclusion: This study showed that natural coagulant aids can reduce the turbidity to below 5NTU without filtration in optimum condition.
Parsian H (phd), Nouri M (phd), Somi Mh (phd), Rahimipour A (phd), Qujeq D (phd), Estakhri R (phd), Kashifard M (phd), Agcheli K(md), Majidi G(md),
Volume 12, Issue 1 (3-2010)
Abstract

Background and Objective: Noninvasive methods have been proposed as surrogate markers for liver biopsy in recent years. It was shown that serum laminin level increases with the development for liver fibrosis The aim of this work was to determine serum laminin level cutoff point for predicting liver fibrosis, highlighting its diagnostic value and determining the effect of treatment on its level. Materials and Methods: In this case-control study during 2008-09, serum laminin levels in chronic hepatitis patients (n=62) and controls (n=20) before the beginning of the treatment and three times in a 2 month's interval i.e. 2.4 and 6 months after the beginning of the treatment- were compared by ELISA and stages of fibrosis were assessed according to the liver biopsy. Results: Mean serum laminin concentration in patients (91.9±20.9 ng/ml) was greater than the control (46.2±10.2 ng/ml, P<0.05). Serum levels of laminin in all stages of hepatic fibrosis were significantly higher than those of the healthy controls (P<0.05). A cutoff point of 52.0 ng/ml of laminin serum was obtained for the discrimination of patients with liver fibrosis than the healthy control showed a good sensitivity (96.8%) and specificity (80%). After 6 months of treatment, a gradual decrease in serum laminin level was observed, however the level was still higher than that of the healthy group (P<0.05). Conclusion: The findings of this study suggest that serum laminin level is a useful non-invasive marker of liver fibrosis due to strong positive correlation between serum laminin level and the degree of liver fibrosis.
Salemi Khamene A , Ghahari Sh , Soltanlou M, Darabi J,
Volume 15, Issue 1 (3-2013)
Abstract

Background and Objective: Autism is one the most disturbing neurodevelopmental disorders associated with any kinds of communicative problems and physical objects. This study was done to evaluate the effectiveness of pivotal response treatment on communicative and behavioral disorder of 8-12 years-old autistic boys. Materials and Methods: This clinical trial study was done on 24 boys with autism (aged between 8-12 years) in pediatric rehabilitation clinic in Tehran, Iran, during 2011. Patients randomly were divided into two groups: control and pivotal response treatment (PRT). The interventional group was received 20 session of PRT during the two months, but the control did not receive any intervention. All patients were examined in the field of social communicative, interactive disorder and self-stimulation behavior, using autism diagnostic interview revised. Data were analyzed using SPSS-16 and MANCOVA test. Results: The mean±SD of social communicative (18.58±0.45), interactive disorder (17.13±0.46), self-stimulations behavior (1.92±0.36) in interventional group were significantly lower than control with following index, 26.33±0.45, 23.11±0.48 and 6.16±0.37, respectively. Conclusion: This study showed that pivotal response treatment can be useful in communicative behavioral disorder of 8-12 years old autistic boys.
Adineh Ha, Motametdi B, Veisi M, Bagheri S,
Volume 16, Issue 2 (7-2014)
Abstract

Background and Objective: Failure of tuberculosis (TB) treatment is a major problem of health systems in developing countries. This study was done to identify the Risk factors of tuberculosis treatment failure in the Sistan and Bulochestan province, the high risk region in South-East of Iran. Methods: This case – control study was carried out on 52 tuberculosis patients (smear -positive and category- I therapy) treated during six months period. Patients with treatment failure were considered as cases and patients with negative smear after 6 months of treatment with anti-tuberculosis (TB) medicines were considered as control group. Demographic, clinical and treatment outcomes were recorded for each patient. The multivariate logistic regression was performed to determine the predictors of treatment failure. Results: Family history of tuberculosis (95% CI: 1-12.56, OR=3.55, P=0.04,), smoking (95% CI:1.58-51.21, OR=9, P=0.01), drug addiction before or during the treatment period (95% CI: 5.28-123.91, OR=25.6, P=0.0001) and low body weight (95% CI:1.05-12.6, OR=3.65, P=0.04) were risk factors for treatment failure. Conclusion: Family history of tuberculosis, weight loss during treatment, smoking and drug addiction, were considered as risk factors for treatment failure in National Tuberculosis Control Programme (NTCP) in south-east of Iran.
Fallah S, Salarilak Sh, Khalkhali Hr, Nejadrahim R , Nasehi M ,
Volume 18, Issue 2 (6-2016)
Abstract

Background and Objective: Tuberculosis (TB) is the main cause of death in the world. Half of the patient eventually will die during first 5-year of infection if they do not receive suitable treatment. According to WHO’s report, treatment success in Iran is lower than the regional and global mean. This study was conducted to identify the effective factors of treatment failure among tuberculosis patient in golestan province- Iran.

Methods: This cross- sectional study was conducted on 331 new smear positive tuberculosis patients that detected in TB laboratory in in golestan province-north of Iran during 2014. Inclusion criteria included weight more than 30kg, age greater than 13 years, diabetes, immune deficiency, liver or kidney diseases. Patients were treated according to a protocol for a period of two months on the DOTS strategy. The criterion of treatment outcome was sputum smear at the end of the second month of treatment. The effect of gender, medication regiment, age, weight, smoking, addiction and severity of smear basilli load on treatment outcome was assessed.

Results: 50.8% and 49.2% of patients were treated with combination and separate medicinal regiments, respectively. The conversion rate of smear positive was 67.7% at the end of the second months. According to multivariate logistic regression, the age of the patient (95% CI: 0.96-0.99, OR: 0.98, P=0.017), addiction (95% CI: 1.26-4.54, OR: 2.4, P=0.008), ethnicity (95% CI: 1.86-7.02, OR: 3.62, P=0.0001) and diagnostic smear bacilli load (P<0.0001) were the important effective variables.

Conclusion: The success of two months treatment was fairly low and the important factors on treatment success during the intensive phase were patient age, smoking, addiction and diagnostic smear bacilli load.


Majid Mahmoud Alilou , Touraj Hashemi Nosratabad , Faeze Sohrabi ,
Volume 19, Issue 4 (12-2017)
Abstract

Background and Objective: General anxiety disorder is one of the chronic disorders in the general population and population with clinical symptoms. This study was conducted to evaluate the efficacy of combined treatment based on acceptance and commitment in the treatment of women with generalized anxiety.
Methods: This multi-faceted, single-subject interventional study was performed on four women with generalized anxiety disorder whom were refered to psychiatric center in Iran. The subjects were selected through targeted clinical sampling by structured diagnostic and clinical interviews based on DSM-V mental disorder diagnostic and diagnostic guidelines. The efficacy of the treatment protocol in three stages (baseline, 12 sessions and 6 week follow up) was assessed using the GAD-7 questionnaire, the Penn State worry questionnaire (PSWQ), and the general scale of anxiety severity and pain (OASIS).
Results: Reduction of symptoms of general anxiety disorder, anxiety, anxiety and performance impairment in patients with generalized anxiety disorder were significant (P<0.05).
Conclusion: Combination therapy based on admission and commitment and coping techniques is effective in the treatment of generalized anxiety disorder in women.

Page 1 from 1     

مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4657